Q-Line Biotech IPO Review
Q-Line Biotech IPO Pages
π
Detailed review coming soon
Our editorial team is preparing an in-depth analysis of Q-Line Biotech IPO covering company financials, valuation, strengths, risks and apply-or-skip verdict. Below is the structured information we have confirmed so far.
Price / Issue Price
βΉ343
Lot Size
400
Type
Sme
Exchange
BSE SME
Sector
Healthcare & Pharma
Already listed.
Issued at βΉ343, listed at βΉ452
(+31.78%)
on 28 May 2026.
IPO Details
- Type
- Sme
- Country
- India
- Sector
- Healthcare & Pharma